Financials

News Ideas Technicals

HRTIS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to HERANTIS PHARMA OYJ operating, investing, and financing activities

HRTIS free cash flow for H2 23 is -2.92 M EUR. For 2023, HRTIS free cash flow was -4.64 M EUR and operating cash flow was -4.64 M EUR.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—